Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Haworth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Toxicologic Pathology|September 13, 2007
Pulmonary neuroendocrine cell hyperplasia: identification, diagnostic criteria and incidence in untreated ageing rats of different strainsRichard Haworth, Jennie Woodfine, Sean McCawley, et al.
Toxicologic Pathology|June 8, 2002
The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigsAndrew M Pilling, Risa M Harman, Stewart A Jones, et al.
Journal of Toxicologic Pathology|December 18, 2014
Nonproliferative and proliferative lesions of the rat and mouse female reproductive systemDarlene Dixon, Roger Alison, Ute Bach, et al.
Mutagenesis|January 6, 2024
N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulationsAnthony M Lynch, Jonathan Howe, Deon Hildebrand, et al.
Toxicologic Pathology|December 3, 2013
Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotideKendall S Frazier, Cécile Sobry, Victoria Derr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2016
Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelPeter Adamson, Thomas Wilde, Eric Dobrzynski, et al.
Toxicologic Pathology|January 18, 2021
BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled BiologicsA Peter Hall, Jeffrey S Tepper, Molly H Boyle, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Toxicologic Pathology|September 13, 2007
Pulmonary neuroendocrine cell hyperplasia: identification, diagnostic criteria and incidence in untreated ageing rats of different strainsRichard Haworth, Jennie Woodfine, Sean McCawley, et al.
Toxicologic Pathology|June 8, 2002
The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigsAndrew M Pilling, Risa M Harman, Stewart A Jones, et al.
Journal of Toxicologic Pathology|December 18, 2014
Nonproliferative and proliferative lesions of the rat and mouse female reproductive systemDarlene Dixon, Roger Alison, Ute Bach, et al.
Mutagenesis|January 6, 2024
N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulationsAnthony M Lynch, Jonathan Howe, Deon Hildebrand, et al.
Toxicologic Pathology|December 3, 2013
Species-specific inflammatory responses as a primary component for the development of glomerular lesions in mice and monkeys following chronic administration of a second-generation antisense oligonucleotideKendall S Frazier, Cécile Sobry, Victoria Derr, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2016
Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelPeter Adamson, Thomas Wilde, Eric Dobrzynski, et al.
Toxicologic Pathology|January 18, 2021
BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled BiologicsA Peter Hall, Jeffrey S Tepper, Molly H Boyle, et al.
Pageof 2